Jupiter Life Line Hospitals Ltd. (JLHL) AI Stock Analysis

• Market Cap: ₹79.91B
• Dividend Yield: 0.14%
• Average Volume (3M): 947.00
• Price to Earnings (P/E): 53.7
• Beta (1Y): 0.08
• Revenue Growth: 18.40%
• EPS Growth: 7.30%
• Country: IN
• Employees: 4,586
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 7.00
• Shares Outstanding: 65,566,025
• 10 Day Avg. Volume: 721
• 30 Day Avg. Volume: 947
• PEG Ratio: 14.64
• Price to Book (P/B): 7.55
• Price to Sales (P/S): 8.12
• P/FCF Ratio: -151.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 32.8
• Revenue Forecast (FY): ₹17.49B

• Rating: 67 Neutral
• Price Target: ₹1,324.00 ▼(-14.17% Downside)
• Action: N/A Date: 10/02/25
• Date: Action: N/A 10/02/25

Jupiter Life Line Hospitals Ltd. has a strong financial foundation with consistent revenue and profit growth, which is the most significant factor. Technical analysis indicates a stable upward trend, but the high P/E ratio suggests overvaluation, impacting the overall score.

Positive Factors

Consistent revenue growth

A 17.4% reported revenue growth indicates durable demand for hospital services and expanding patient volumes or pricing. Sustained top-line growth supports capacity utilization, reinvestment in facilities and specialties, and underpins multi-quarter financial planning.

Negative Factors

Negative free cash flow trend

Persistent negative free cash flow growth despite solid operating cash flow suggests heavy capex, working capital strain, or timing mismatches. Over time this can force external financing, constrain organic expansion, or limit returns to shareholders if not corrected.

Jupiter Life Line Hospitals Ltd. Business Overview & Revenue Model

Company Description

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company provides treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, ch...

Read more

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company provides treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, ch...

How the Company Makes Money

JLHL primarily makes money by delivering hospital-based healthcare services to patients and billing for these services through a mix of self-pay patients, private/commercial insurance, and government/third-party payer programs (where applicable). ...

Read more

JLHL primarily makes money by delivering hospital-based healthcare services to patients and billing for these services through a mix of self-pay patients, private/commercial insurance, and government/third-party payer programs (where applicable). ...

Jupiter Life Line Hospitals Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	13.93B	12.62B	10.70B	8.93B	7.33B	4.86B
Gross Profit	11.31B	10.31B	8.55B	7.11B	4.07B	2.41B
EBITDA	3.63B	3.25B	2.61B	2.06B	1.50B	637.55M
Net Income	1.98B	1.93B	1.77B	729.05M	511.28M	-22.97M
Balance Sheet
Total Assets	20.23B	19.05B	12.81B	9.86B	9.09B	7.89B
Cash, Cash Equivalents and Short-Term Investments	5.64B	6.03B	3.18B	1.36B	1.06B	266.46M
Total Debt	4.03B	3.93B	623.41M	4.69B	4.95B	4.26B
Total Liabilities	5.72B	5.49B	1.13B	6.22B	6.20B	5.42B
Stockholders Equity	14.51B	13.56B	11.69B	3.66B	2.94B	2.39B
Cash Flow
Free Cash Flow	-403.95M	-674.22M	292.26M	399.24M	452.40M	-1.18B
Operating Cash Flow	1.30B	2.53B	1.15B	1.17B	1.37B	1.23B
Investing Cash Flow	-1.73B	-2.09B	-758.89M	-1.04B	-852.46M	-2.96B
Financing Cash Flow	-231.75M	3.01B	1.28B	175.00M	322.02M	1.84B

Jupiter Life Line Hospitals Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1542.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JLHL, the sentiment is Negative. The current price of 1542.6 is above the 20-day moving average (MA) of 1253.94, above the 50-day MA of 1262.70, and above the 200-day MA of 1407.86, indicating a bearish trend. The MACD of -13.86 indicates Positive momentum. The RSI at 40.69 is Neutral, neither overbought nor oversold. The STOCH value of 14.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JLHL.

Jupiter Life Line Hospitals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NH	71 Outperform	₹351.19B	75.82	―	0.24%	14.72%	8.37%
JLHL	67 Neutral	₹79.91B	53.67	―	0.14%	18.40%	7.30%
KIMS	65 Neutral	₹265.83B	114.01	―	―	25.74%	1.41%
MEDANTA	65 Neutral	₹284.55B	83.79	―	0.04%	15.78%	15.01%
ASTERDM	62 Neutral	₹345.30B	151.95	―	0.84%	-36.14%	-93.99%
FORTIS	61 Neutral	₹634.35B	86.12	―	0.11%	15.33%	54.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Jupiter Life Line Hospitals Ltd. Corporate Events